Celldex Therapeutics
CLDX
#4657
Rank
HK$13.05 B
Marketcap
HK$196.85
Share price
-0.98%
Change (1 day)
-30.09%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.70. In 2022 the company made an earnings per share (EPS) of -HK$18.62 a decrease over its 2021 EPS that were of -HK$12.78.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.811%
2022-HK$18.6245.73%
2021-HK$12.78-23.36%
2020-HK$16.68-41.05%
2019-HK$28.29-76.95%
2018-HK$122.7445.03%
2017-HK$84.63-42.54%
2016-HK$147.28-3.82%
2015-HK$153.13-0.76%
2014-HK$154.3029.41%
2013-HK$119.230%
2012-HK$119.23-9.73%
2011-HK$132.091312.5%
2010-HK$9.35-95.79%
2009-HK$221.92-49.64%
2008-HK$440.68-82.64%
2007-HK$2,539-44.98%
2006-HK$4,6151270.83%
2005-HK$336.6533.33%
2004-HK$252.49-10%
2003-HK$280.54-16.67%
2002-HK$336.65-38.46%
2001-HK$547.05-4.88%
2000-HK$575.11-81.66%
1999-HK$3,135-87.2%
1998-HK$24,483206.39%
1997-HK$7,99113.02%
1996-HK$7,070

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.25 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.62-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$94.14 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.27-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.49-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.28-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.44-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA